Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/11/2025

Pulmonary Hypertension Treatment Guidelines

Classification and Treatment Approach

  • The European Respiratory Society recommends classifying pulmonary hypertension into five groups based on etiology, with different treatment approaches for each 1
  • Current guidelines suggest treating the underlying condition causing pulmonary hypertension before considering specific pulmonary hypertension therapies, as recommended by the European Respiratory Society 3, 4
  • For pulmonary hypertension due to lung diseases, optimization of the underlying lung disease and long-term oxygen therapy for hypoxemic patients are the mainstays of treatment, according to the European Respiratory Society 2, 5
  • The European Respiratory Society recommends aggressive treatment of the underlying heart failure or valvular disease for pulmonary hypertension due to left heart disease 6

Established Treatments for Different Types of Pulmonary Hypertension

  • For pulmonary hypertension due to lung diseases, the European Respiratory Society recommends long-term oxygen therapy for hypoxemic patients 2, 5
  • Conventional vasodilators like calcium channel blockers are not recommended for pulmonary hypertension due to lung diseases, as they may impair gas exchange, according to the European Respiratory Society 2
  • The European Respiratory Society does not recommend PAH-specific therapies for patients with pulmonary hypertension due to lung disease 2, 5
  • For pulmonary hypertension due to left heart disease, optimization of heart failure treatment with ACE inhibitors/ARBs, beta-blockers, and diuretics is recommended by the European Respiratory Society 6
  • The European Respiratory Society suggests repair of valvular heart disease when indicated, for pulmonary hypertension due to left heart disease 7
  • PAH-specific therapies are not recommended for pulmonary hypertension due to left heart disease, according to the European Respiratory Society 6, 4

Clinical Implications and Cautions

  • Using medications without established evidence in pulmonary hypertension can potentially worsen outcomes, as has been seen with other drug classes, as noted in the European Respiratory Journal 8
  • Patients with suspected pulmonary hypertension should be referred to specialized pulmonary hypertension centers for proper diagnosis and treatment planning, as recommended by the European Respiratory Society 1, 5
  • Definitive diagnosis of pulmonary hypertension requires right heart catheterization, which is essential before initiating specific therapies, according to the European Respiratory Society 2, 5

REFERENCES

7

Treatment of Congestive Heart Failure with Pulmonary Hypertension [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025